West Michigan-developed diabetes drug to be studied as a treatment for Alzheimer’s disease
Metabolic Solutions Development Co. (MSDC) has received a $100,000 grant from the Alzheimer’s Drug Discovery Foundation to study the effectiveness of MSDC’s proprietary diabetes compound MSDC-0160 in treating Alzheimer’s disease. The grant will fund collaboration between Dr. Douglas Feinstein of the University of Illinois – Chicago, the Jesse Brown VA Medical Center and MSDC. MSDC, […]

